A Message from Program Leaders
Dear Prospective Applicants:
We invite you to explore the rich offerings afforded by our Hematology/Oncology Fellowship Training Program at Beth Israel Deaconess Medical Center (BIDMC), a major teaching affiliate of Harvard Medical School.
For over 40 years, we have offered rigorous clinical training coupled with world-class faculty expertise and mentorship at the leading-edge of Hematology/Oncology. Reflective of the exponential growth in our understanding of the scientific basis of human disease, comprehensive models of compassionate patient care, and diversity of career opportunities that now exist within our vast discipline, we have evolved our program to include three highly individualized and innovative longitudinal pathways for deliberate career development:
- Traditional Hematology/Oncology Track
- Hematology/Oncology & Hospice and Palliative Medicine Track
- Hematology Track
Each year, our program seeks to recruit seven new exceptionally qualified fellows: six in Hematology/Oncology and Hematology/Oncology & Hospice and Palliative Medicine; one in Hematology.
In 2022, BIDMC was one of nine institutions nationwide selected to receive the prestigious Hematology-Focused Fellowship Training Program (HFFTP) award, granted by the American Society of Hematology (ASH).
In 2023, BIDMC additionally joined an elite cohort of programs nationwide participating in the American Society of Clinical Oncology (ASCO)-sponsored Advancing Innovation in Residency Education (AIRE) ACGME pilot program to offer a combined fellowship training experience in Hematology/Oncology and Hospice and Palliative Medicine.
Our aim is to produce scholars who will devote their careers, in different proportions, to excellence in clinical care, teaching, and clinical/basic research. Every effort is made to tailor the experience to the individual interests and needs of our trainees. We expect that all graduates of our program will become first-class clinicians, teachers, and investigators. In recognition of the program's success in producing physician-scientists, the NIH has provided training grant support to the program for over 30 years.
We have diverse and active clinical investigative initiatives in:
- hematopoietic cell transplantation
- biologic and immunotherapies
- cellular therapies
- genitourinary malignancies
- breast cancer
- lung cancer
- head and neck cancer
- gastrointestinal malignancies
- AIDS-related malignancies
- developmental therapeutics
- hemostasis and thrombosis
Basic research programs include:
- signal transduction and growth regulation
- the role of transcription factors in hematopoiesis
- molecular analysis of hematopoietic stem cell differentiation
- biology of prostate cancer and the molecular basis of hormone-independent prostate cancer growth
- biology of AIDS-related malignancies
- T-cell receptor biology as applied to gene therapy
- hemostasis, thrombosis, and vascular biology
- cancer-related thrombosis
- platelet biology
- molecular retrovirology and HIV-gene therapy
- the immunobiology of cytokines
- cellular therapies
We welcome you to explore our website in detail and learn more about us. Please feel free to contact us with any questions you may have or to discuss your areas of interest.
Dr. Deepa Rangachari, Director of Graduate Medical Education & Fellowship Program Director
Dr. Rushad Patell, Associate Fellowship Program Director
Dr. Reed Drews, Emeritus Fellowship Program Director, Associate Program Director Hematology-Focused Fellowship Training Program
Ms. Roshanda Leak, Program Coordinator, Hematology/Oncology & Hematology-Focused Fellowship Training Programs
Hematology/Oncology Leadership & Faculty
Learn more about BIDMC's Hematology/Oncology Fellowship Program faculty below.
Dr. Deepa Rangachari
Director of Graduate Medical Education & Fellowship Program Director
Dr. Rushad Patell
Associate Fellowship Program Director
Dr. Reed Drews
Emeritus Fellowship Program Director, Associate Fellowship Program Director (HFFTP)
Fellowship Program Coordinator
Dr. Daniel Costa
Scholarship Advisor for Medical Oncology
Dr. Jacalyn Rosenblatt
Scholarship Advisor for Hematology and Hematologic Malignancies